SEC Info℠

Home

Search

My Interests

Help

Sign In

Please Sign In

Novo Integrated Sciences, Inc. – ‘S-1/A’ on 10/4/22

On:  Tuesday, 10/4/22, at 4:37pm ET   ·   Accession #:  1493152-22-27562   ·   File #:  333-267401

Previous ‘S-1’:  ‘S-1’ on 9/13/22   ·   Next & Latest:  ‘S-1/A’ on 10/7/22   ·   35 References:   To:  Novo Integrated Sciences, Inc. – Previous ‘S-1’ on 9/13/22 To:  Novo Integrated Sciences, Inc. – ‘8-K’ on 4/7/22 for 4/5/22 To:  Novo Integrated Sciences, Inc. – ‘8-K’ on 3/23/22 for 3/17/22 To:  Novo Integrated Sciences, Inc. – ‘10-Q’ on 1/18/22 for 11/30/21 To:  Novo Integrated Sciences, Inc. – ‘8-K’ on 12/15/21 for 12/14/21 To:  Novo Integrated Sciences, Inc. – ‘10-K’ on 12/14/21 for 8/31/21 To:  Novo Integrated Sciences, Inc. – ‘8-K’ on 11/24/21 for 11/17/21 To:  Novo Integrated Sciences, Inc. – ‘8-K’ on 10/28/21 for 10/22/21 To:  Novo Integrated Sciences, Inc. – ‘8-K’ on 10/14/21 for 10/7/21 To:  Novo Integrated Sciences, Inc. – ‘8-K’ on 9/23/21 for 9/22/21 To:  Novo Integrated Sciences, Inc. – ‘8-K’ on 6/21/21 for 6/14/21 To:  Novo Integrated Sciences, Inc. – ‘8-K’ on 6/3/21 for 5/28/21 To:  Novo Integrated Sciences, Inc. – ‘8-K’ on 5/17/21 for 5/11/21 To:  Novo Integrated Sciences, Inc. – ‘8-K’ on / for 4/9/21 To:  Novo Integrated Sciences, Inc. – ‘8-K’ on 2/16/21 for 2/9/21 To:  Novo Integrated Sciences, Inc. – ‘10-K’ on 12/9/20 for 8/31/20 To:  Novo Integrated Sciences, Inc. – ‘8-K’ on 11/30/20 for 11/23/20 To:  Novo Integrated Sciences, Inc. – ‘8-K’ on 8/12/20 for 8/6/20 To:  Novo Integrated Sciences, Inc. – ‘8-K’ on 3/12/20 for 3/9/20 To:  Novo Integrated Sciences, Inc. – ‘8-K’ on 2/10/20 for 2/4/20 To:  Novo Integrated Sciences, Inc. – ‘8-K’ on 9/30/19 for 9/24/19 To:  Novo Integrated Sciences, Inc. – ‘8-K’ on 9/17/19 for 9/11/19 To:  Novo Integrated Sciences, Inc. – ‘8-K’ on 3/5/19 for 2/26/19 To:  Novo Integrated Sciences, Inc. – ‘10-Q’ on 1/11/19 for 11/30/18 To:  Novo Integrated Sciences, Inc. – ‘8-K’ on 12/6/18 for 11/30/18 To:  Novo Integrated Sciences, Inc. – ‘8-K’ on / for 7/27/18 To:  Novo Integrated Sciences, Inc. – ‘8-K’ on 4/24/18 for 4/8/18 To:  Novo Integrated Sciences, Inc. – ‘8-K’ on 1/22/18 for 1/16/18 To:  Novo Integrated Sciences, Inc. – ‘8-K’ on 1/3/18 for 12/29/17 To:  Novo Integrated Sciences, Inc. – ‘8-K’ on 7/18/17 for 7/12/17 To:  Novo Integrated Sciences, Inc. – ‘8-K’ on 6/5/17 for 5/30/17 To:  Novo Integrated Sciences, Inc. – ‘8-K’ on 5/9/17 for 4/25/17 To:  Novo Integrated Sciences, Inc. – ‘8-K’ on 5/1/17 for 4/25/17 To:  Novo Integrated Sciences, Inc. – ‘10-K’ on 3/7/17 for 12/31/16 To:  Novo Integrated Sciences, Inc. – ‘S-8’ on 9/8/15 

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

 Text Wildcards:  ? (any letter/digit),  * (many).  Search Logic:  for Documents:  & (and),  | (or);  for Text:  | (anywhere),  "(&)" (near).  Details... 

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/04/22  Novo Integrated Sciences, Inc.    S-1/A                 18:1.4M                                   M2 Compliance LLC/FA

Document/Exhibit                   Description                      Pages   Size 

 1: S-1/A       Pre-Effective Amendment to Registration Statement   HTML    274K 
                (General Form)                                                   
 2: EX-1.1      Underwriting Agreement or Conflict Minerals Report  HTML    126K 
 3: EX-4.6      Instrument Defining the Rights of Security Holders  HTML    130K 
 4: EX-4.7      Instrument Defining the Rights of Security Holders  HTML    122K 
 5: EX-4.8      Instrument Defining the Rights of Security Holders  HTML    106K 
 6: EX-5.1      Opinion of Counsel re: Legality                     HTML     30K 
 7: EX-10.56    Material Contract                                   HTML    275K 
 8: EX-FILING FEES  Filing Fees                                     HTML     25K 
13: R1          Cover                                               HTML     44K 
16: XML         IDEA XML File -- Filing Summary                      XML     15K 
14: XML         XBRL Instance -- forms-1a_htm                        XML     20K 
15: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
10: EX-101.DEF  Inline XBRL Taxonomy Extension Definition Linkbase   XML     75K 
                Document -- nvos-20220531_def                                    
11: EX-101.LAB  Inline XBRL Taxonomy Extension Label Linkbase        XML    104K 
                Document -- nvos-20220531_lab                                    
12: EX-101.PRE  Inline XBRL Taxonomy Extension Presentation          XML     72K 
                Linkbase Document -- nvos-20220531_pre                           
 9: EX-101.SCH  Inline XBRL Taxonomy Extension Schema Document --    XSD     15K 
                nvos-20220531                                                    
17: JSON        XBRL Instance as JSON Data -- MetaLinks               27±    37K 
18: ZIP         XBRL Zipped Folder -- 0001493152-22-027562-xbrl      Zip    213K 

As filed with the U.S. Securities and Exchange Commission on October 4, 2022

Registration No. 333-267401

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Pre-Effective Amendment No. 1 to

Form S-1

REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933

 i NOVO INTEGRATED SCIENCES, INC.

(Exact name of registrant as specified in its charter)

Novo Integrated Sciences, Inc.

 i 11120 NE 2nd Street,  i Suite 100

 i Bellevue,  i WA  i 98004

Telephone:  i (206)  i 617-9797
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 i Robert Mattacchione

Chief Executive Officer

Novo Integrated Sciences, Inc.

 i 11120 NE 2nd Street,  i Suite 100

 i Bellevue,  i WA  i 98004

Telephone:  i (206)  i 617-9797

(Name, address, including zip code, and telephone number, including area code, of agent for service)

Copies to:

Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration statement.

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box. ☒

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check market if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date as the Commission, acting pursuant to Section 8(a) may determine.

EXPLANATORY NOTE

 i This Pre-Effective Amendment No. 1 is being filed solely for the purpose of filing Exhibits 1.1, 4.6, 4.7, 4.8, 5.1,10.56 and 107 to this registration statement on Form S-1, or the Registration Statement, and to amend and restate the exhibit index set forth in Part II of the Registration Statement. No changes have been made to the Registration Statement other than this explanatory note and exhibit index of the Registration Statement. This Pre-Effective Amendment No. 1 does not contain copies of the prospectus included in the Registration Statement, which remains unchanged from the Registration Statement filed on September 13, 2022.

PART II

INFORMATION NOT REQUIRED IN PROSPECTUS

The following table sets forth all expenses to be paid by the registrant, other than estimated underwriting discounts and commissions, in connection with our public offering. All amounts shown are estimates except for the SEC registration fee and the FINRA filing fee:

The Company’s amended and restated articles of incorporation provide that no director or officer of the Company shall be personally liable to the Company or any of its stockholders for damages for breach of fiduciary duty as a director or officer of for any act or omission of any such director or officer; however such indemnification shall not eliminate or limit the liability of a director or officer for (a) acts or omissions which involve intentional misconduct, fraud or a knowing violation of law or (b) the payment of dividends in violation of Section 78.300 of the Nevada Revised Statutes. The Company’s Bylaws (the “Bylaws”) provide that any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that such person is or was a director, officer, employee or agent of the Company (or is or was serving at the request of the Company as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise) shall be indemnified and held harmless by the Company to the fullest extent permitted by Nevada law against expenses including attorneys’ fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such proceeding.

The Bylaws also provide that the Company must indemnify any person who was or is a party, or is threatened to be made a party, to any threatened, pending or completed proceeding by or in the right of the Company to procure a judgment in its favor by reason of the fact that such person is or was a director, officer, employee or agent of the Company, or is or was serving at the request of the Company as a director, officer, employee, or agent of another corporation, partnership, joint venture, trust or other enterprise against costs incurred by such person in connection with the defense or settlement of such action or suit. Such indemnification may not be made for any claim, issue or matter as to which such person has been adjudged by a court of competent jurisdiction, after exhaustion of all appeals, to be liable to the Company or for amounts paid in settlement to the Company, unless and only to the extent that the court determines upon application that in view of all the circumstances of the case, the person is fairly and reasonably entitled to indemnity for such expenses as the court deems proper.

The Bylaws provide that the Company must pay the costs incurred by any person entitled to indemnification in defending a proceeding as such costs are incurred and in advance of the final disposition of a proceeding; provided however, that the Company must pay such costs only upon receipt of an undertaking by or on behalf of such person to repay the amount if it is ultimately determined by a court of competent jurisdiction that such person is not entitled to be indemnified by the Company.

The Bylaws provide that the Company may purchase and maintain insurance or make other financial arrangements on behalf of any person who is or was a director, officer, employee or agent of the Company, or is or was serving at the request of the Company as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise in accordance with Section 78.752 of the Nevada Revised Statutes.

Nevada Revised Statutes 78.751 and 78.7502 have provisions that provide for discretionary and mandatory indemnification of officers, directors, employees, and agents of a corporation. Under these provisions, such persons may be indemnified by a corporation against expenses, including attorney’s fees, judgment, fines and amounts paid in settlement, actually and reasonably incurred by him in connection with the action, suit or proceeding, if he is not liable pursuant to Section 78.138 of the Nevada Revised Statutes or he acted in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the corporation and with respect to any criminal action or proceeding had no reasonable cause to believe his conduct was unlawful.

To the extent that a director, officer, employee or agent has been successful on the merits or otherwise in defense of any action, suit or proceeding, or in defense of any claim, issue or matter, the Nevada Revised Statues provide that he must be indemnified by the Company against expenses, including attorney’s fees, actually and reasonably incurred by him in connection with the defense.

Section 78.751 of the Nevada Revised Statues also provides that any discretionary indemnification, unless ordered by a court or advanced by the Company, may be made only as authorized in the specific case upon a determination that indemnification of the director, officer, employee or agent is proper in the circumstances. The determination must be made:

Insofar as the limitation of, or indemnification for, liabilities arising under the Securities Act may be permitted to directors, officers, or persons controlling us pursuant to the foregoing, or otherwise, we have been advised that, in the opinion of the SEC, such limitation or indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.

The following is a summary of transactions since December 5, 2017 involving unregistered issuances of our common equity securities.

During the fiscal year ended August 31, 2018, the Company:

During the fiscal year ended August 31, 2019, the Company engaged in the following stock issuances:

During the fiscal year ended August 31, 2020, the Company engaged in the following stock issuances that were not registered under the Securities Act:

During the fiscal year ended August 31, 2021, the Company engaged in the following stock issuances that were not registered under the Securities Act:

During the period from September 1, 2021 through May 31, 2022, the Company engaged in the following stock issuances that were not registered under the Securities Act:

Except for the issuances made on March 4, 2019 and March 13, 2020, the above issuances and sales were made pursuant to an exemption from registration as set forth in Regulation S under the Securities Act. The issuances involved an offer and sale of securities outside the United States. The offers and sales were made in offshore transactions and no directed selling efforts were made by the issuer, a distributor, their affiliates or any persons acting on their behalf. The issuances on March 4, 2019 and March 13, 2020 were made pursuant to an exemption from registration as set forth in 506 of Regulation D and Section 4(2) of the Securities Act.

The undersigned registrant hereby undertakes:

(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

(i) To include any prospectus required by section 10(a)(3) of the Securities Act of 1933, as amended (the “Securities Act”);

(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and

(iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; provided, however, that paragraphs (1)(i), (1)(ii) and (1)(iii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Securities and Exchange Commission by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.

(2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

(4) That, for the purpose of determining liability under the Securities Act to any purchaser:

(A) Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and

(B) Each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.

(5) That for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

(i) Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;

(ii) Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;

(iii) The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and

(iv) Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to any charter provision, by law or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

The undersigned registrant hereby undertakes that:

(1) For purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.

(2) For the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof

EXHIBIT INDEX

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this Pre-Effective Amendment No. 1 to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Bellevue, State of Washington on October 4, 2022.

Pursuant to the requirements of the Securities Act, Pre-Effective Amendment No. 1 to the Registration Statement has been signed by the following persons in the capacities held on October 4, 2022.

---

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘S-1/A’ Filing		Date		Other Filings
Filed on:		10/4/22
		9/13/22		S-1
		5/31/22		10-Q
		5/11/22
		5/2/22
		4/20/22
		4/7/22		8-K
		4/5/22		8-K
		3/18/22
		3/17/22		8-K
		2/24/22		4,  8-K
		1/24/22
		12/20/21
		11/23/21		8-K
		11/17/21		8-K
		9/16/21
		9/1/21
		8/31/21		10-K,  NT 10-K
		6/24/21		8-K,  8-K/A
		5/28/21		8-K
		5/24/21		8-K
		3/1/21		8-K
		2/1/21		8-K
		12/15/20		8-K
		12/11/20
		11/16/20
		11/13/20		8-K
		10/26/20
		10/22/20
		10/21/20
		10/20/20
		9/24/20
		8/31/20		10-K,  NT 10-K
		8/10/20
		7/31/20
		7/21/20		8-K
		3/13/20
		3/9/20		8-K
		3/6/20
		12/20/19
		12/17/19		8-K
		10/22/19
		10/19/19
		10/15/19
		10/12/19
		8/31/19		10-K
		7/26/19
		7/22/19
		7/19/19
		6/6/19
		6/4/19
		5/7/19
		5/3/19
		5/1/19
		4/30/19
		4/24/19
		4/19/19
		4/5/19
		4/3/19
		3/4/19
		2/26/19		8-K
		1/30/19
		1/18/19
		1/15/19
		1/8/19
		12/20/18
		12/18/18		8-K
		11/20/18		8-K
		11/16/18
		8/31/18		10-K
		2/9/18
		12/5/17
				List all Filings

---

35 Previous Filings that this Filing References

As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/13/22 Novo Integrated Sciences, Inc. S-1 101:17M M2 Compliance LLC/FA 4/07/22 Novo Integrated Sciences, Inc. 8-K:5,7,8,9 4/05/22 12:510K M2 Compliance LLC/FA 3/23/22 Novo Integrated Sciences, Inc. 8-K:1,7,9 3/17/22 12:867K M2 Compliance LLC/FA 1/18/22 Novo Integrated Sciences, Inc. 10-Q 11/30/21 92:8.1M M2 Compliance LLC/FA 12/15/21 Novo Integrated Sciences, Inc. 8-K:1,5,9 12/14/21 17:1.9M M2 Compliance LLC/FA 12/14/21 Novo Integrated Sciences, Inc. 10-K 8/31/21 103:9.7M M2 Compliance LLC/FA 11/24/21 Novo Integrated Sciences, Inc. 8-K:1,2,9 11/17/21 9:1.4M M2 Compliance LLC/FA 10/28/21 Novo Integrated Sciences, Inc. 8-K:1,9 10/22/21 2:141K M2 Compliance LLC/FA 10/14/21 Novo Integrated Sciences, Inc. 8-K:1,7,9 10/07/21 3:124K M2 Compliance LLC/FA 9/23/21 Novo Integrated Sciences, Inc. 8-K:1,7,9 9/22/21 3:107K M2 Compliance LLC/FA 6/21/21 Novo Integrated Sciences, Inc. 8-K:5,9 6/14/21 3:271K M2 Compliance LLC/FA 6/03/21 Novo Integrated Sciences, Inc. 8-K:1,7,9 5/28/21 3:636K M2 Compliance LLC/FA 5/17/21 Novo Integrated Sciences, Inc. 8-K:1,7,9 5/11/21 3:576K M2 Compliance LLC/FA 4/09/21 Novo Integrated Sciences, Inc. 8-K:1,3,8,9 4/09/21 6:668K M2 Compliance LLC/FA 2/16/21 Novo Integrated Sciences, Inc. 8-K:5,9 2/09/21 2:507K M2 Compliance LLC/FA 12/09/20 Novo Integrated Sciences, Inc. 10-K 8/31/20 85:6.1M M2 Compliance LLC/FA 11/30/20 Novo Integrated Sciences, Inc. 8-K:5,9 11/23/20 4:2.7M M2 Compliance LLC/FA 8/12/20 Novo Integrated Sciences, Inc. 8-K:5,7,9 8/06/20 4:150K M2 Compliance LLC/FA 3/12/20 Novo Integrated Sciences, Inc. 8-K:1,4,9 3/09/20 3:88K M2 Compliance LLC/FA 2/10/20 Novo Integrated Sciences, Inc. 8-K:1,9 2/04/20 3:127K M2 Compliance LLC/FA 9/30/19 Novo Integrated Sciences, Inc. 8-K:1,9 9/24/19 5:848K M2 Compliance LLC/FA 9/17/19 Novo Integrated Sciences, Inc. 8-K:1,9 9/11/19 2:116K M2 Compliance LLC/FA 3/05/19 Novo Integrated Sciences, Inc. 8-K:1,9 2/26/19 4:391K M2 Compliance LLC/FA 1/11/19 Novo Integrated Sciences, Inc. 10-Q 11/30/18 62:2.7M M2 Compliance LLC/FA 12/06/18 Novo Integrated Sciences, Inc. 8-K:5,9 11/30/18 2:52K M2 Compliance LLC/FA 7/27/18 Novo Integrated Sciences, Inc. 8-K:5,9 7/27/18 2:51K M2 Compliance LLC/FA 4/24/18 Novo Integrated Sciences, Inc. 8-K:1,5,9 4/08/18 6:187K M2 Compliance LLC/FA 1/22/18 Novo Integrated Sciences, Inc. 8-K:5,9 1/16/18 2:283K M2 Compliance LLC/FA 1/03/18 Novo Integrated Sciences, Inc. 8-K:5,7,9 12/29/17 4:164K M2 Compliance LLC/FA 7/18/17 Novo Integrated Sciences, Inc. 8-K:5,9 7/12/17 3:76K Discount Edgar/FA 6/05/17 Novo Integrated Sciences, Inc. 8-K:4,5,9 5/30/17 3:285K Discount Edgar/FA 5/09/17 Novo Integrated Sciences, Inc. 8-K:1,9 4/25/17 2:31K Discount Edgar/FA 5/01/17 Novo Integrated Sciences, Inc. 8-K:1,7,9 4/25/17 3:253K Discount Edgar/FA 3/07/17 Novo Integrated Sciences, Inc. 10-K 12/31/16 52:4.4M Discount Edgar/FA 9/08/15 Novo Integrated Sciences, Inc. S-8 9/08/15 4:155K Discount Edgar/FA

↑Top

---

Filing Submission 0001493152-22-027562   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

---

---

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Fri., Apr. 19, 6:07:34.3am ET